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Abstract 
 
Motivation is factor that induces patients to seek treatment options, accomplish treatment guidelines and perform constructive 
activities to achieve long-term result and positive changes. Aim of the study was to determine whether there is statistically 
significant differences in treatment motivation between substance use disorder patients participating in Minnesota program and 
Methadone program. There were 3 research tools: Demographic questionnaire, SOCRATES 8A/8D, and Treatment motivation 
questionnaire. It was found that mean values of substance use disorder patients in Minnesota program were statistically 
significantly higher than patients from Methadone program. Motivation aspects to treat are significant higher in respondents who 
participated in treatment with biopsychosocial intervention comparing to pharmacotherapeutic intervention.  
© 2015 The Authors. Published by Elsevier Ltd. 
Peer-review under responsibility of Academic World Research and Education Center. 
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___________________________________________________________________________________________ 
 
1. Introduction 
 
For effective treatment of Substance use disorder (SUD) and achieving behavioural changes strong motivation 
from the patient is required. 
Motivation of SUD patients has come into attention of researchers in the aspect of finding out how to improve 
motivation of addicted patients to cease the use of psychoactive substances (PAS) and start the treatment as well as 
to keep the positive dynamics after the treating process.  
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As Miller (1999) pointed out, motivation is the key for changes, it is multidimensional, dynamical, fluctuating, 
has an impact on social interaction, which makes it important for the specialist to detect the characteristics of 
patient’s motivation and gradually improve it.   
On the way to achieving higher motivation and decision for participating in the treatment, PAS addict needs to 
find balance as well as take into account the advantages and disadvantages of stopping use of substances and/or 
participation in the treatment (Stevens et al., 2015). This heterogeneity of motivation can be explained by many 
internal and external factors, including demographic situation, ways of dealing with stress, severity of SUD,  
consequences of substance misuse, psychiatric co-morbidities, the quality of environment and life and duration of  
positive results after previous therapies applied (DiClemente et al., 2009; Drieschner et al., 2004; Ryan, Plant & 
O'Malley, 1995).  
Several studies show that individuals with advanced external motivation more frequently seek for ways of 
treating their condition, for instance, patients with more pronounced stress in life, problems with law or work 
(Weisner et al., 2002), under social pressure, with more severe disease and disease related problems (Tucker et al., 
2004) or when difficulties occur which interfere with daily functioning (Simpson, Tucker, 2004; Ogborne, DeWit, 
1999).  
Often in cases where problem recognition or decision on quitting PAS use is required, the importance of internal 
motivation is emphasized (Plant & O'Malley, 1995; Le Berre et al., 2012; Cahill et al., 2003). Internal motivation is 
associated with greater patient involvement and retention in treatment (Ryan, Plant & O'Malley, 1995). The results 
of many studies show that subjects high in both internal and external motivation demonstrated the best attendance 
and treatment retention while those low in internal motivation showed the poorest treatment retention and the 
poorest treatment response, regardless of the level of external motivation (Ryan, Plant & O'Malley, 1995). 
In Le Berre’s study (Le Berre et al., 2012) it was concluded, that it is essential to improve cognitive abilities of 
patients eventually leading to better understanding of their addiction and solving their ambivalent thoughts and 
feelings towards their addiction, to activate the desire to alter their problematic behaviour. It can be achieved 
through motivational interviews, through patient centred and directive way of treating (Hettema et al, 2005; Miller, 
Rose, 2009). 
Taking into account that substitution therapy does not require active participation in the psychosocial 
rehabilitation, apart from receiving the medicine, whereas in Minnesota program active participation is essential, 
which leads to assumption that Minnesota program participants ought to have higher motivation than participants of 
Methadone substitution program.  
 
2. Material and methods  
 
208 SUD patients took part in this study- 108 from Minnesota program and 100 from Methadone program. 
Participants were from 17 to 67 years old, all of them being diagnosed with Substance Use Disorder according to 
ICD-10 classification. All of participants gave an informed confirmation. For the purpose of this research, 
permission was received from Ethics Committee of Riga Stradins University. 
Patients had to fill 3 questionnaires (Socio-demographic questionnaire, SOCRATES 8A/ SOCRATES 8D 
questionnaire and Treatment motivation questionnaire). The Socio-demographic questionnaire was developed by the 
authors of study. It consists of 19 questions, including basic information of the patient (gender, age, education, 
employment, and family status), the addictive substance used, consequences of addiction and patient’s view on 
whether the addiction is present. 
SOCRATES 8A/ SOCRATES 8D questionnaires (The Stages of Change Readiness and Treatment Eagerness 
Scale, Miller & Tonigan, 1996) consist of 19 questions and 3 subscales, five-point Likert scale (1=strongly disagree; 
5=strongly agree) are used. The first subscale ‘Recognition’, possible score being from 7 to 35, showed whether the 
subject recognizes his problems and whether he is willing to embrace changes (for example, I have serious problems 
with drugs). The second subscale ‘Ambivalence’ (4-20 points) shows openness to reflection (for example, 
Sometimes I wonder if my drug use is hurting other people). The third subscale ‘Taking Steps’ (8-40 points) shows 
whether the subject is already doing something to make a positive change in his behavior (for example, I am actively 
doing things now to cut down or stop my use of drugs). The Socrates questionnaire data were processed in SPSS 
program and it was found that the Cronbach’s alpha for the questionnaire is 0.71 thus meaning that the questionnaire 
is consistent. 
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Treatment motivation questionnaire (TMQ; Ryan, Plant & O’Malley, 1995) consists of 26 questions which are 
arranged in 4 subscales, seven-point Likert scale (1=not at all; 7=very true) are used. The first subscale ‘External 
Reasons’ consisted of items reflecting the subject’s perceived lack of choice in seeking treatment and the experience 
of external pressure to remain in treatment (for example, I’ll get in trouble if I don’t remain in the treatment). The 
second subscale ‘Internal Reasons’ consisted of items reflecting identified and interjected motivational dynamics 
(for example, I came for treatment at the clinic because it is important to me personally to solve my problems). The 
third subscale ‘Confidence’ consisted of items reflecting the subject’s expectation of a positive treatment outcome 
(for example, I am confident this program will work for me). The fourth- ‘Help Seeking’ measured motivation to 
share problems and relate to others during the course of treatment (for example, I want to openly relate with others 
in the program). It was found that Cronbach’s alpha value was 0.73, meaning that the research tool is consistent. 
 
3. Data analysis 
 
For socio-demographic questionnaires the descriptive statistics analysing method was used. Concluding statistics 
analysing method was used by Statistical Package for the Social Sciences (SPSS), 17th version. Data were 
calculated with T-test, as the results correspond to normal distribution from Kolmogorov- Smirnov test. 
 
5. Results 
208 SUD patients were questioned during the research (108 from Minnesota and 100 from Methadone program), 
201 questionnaires were completed thoroughly and therefore valid for further evaluation. All in all, data about 102 
Minnesota program patients and 99 Methadone program patients were analysed. Respondents were 17 to 67 years 
old (mean 38.24 ±10.28), 36.3% women and 63.7% men. Demographic data are shown in table 1.  
 
Table 1. Demographic data of Respondents 
 Minnesota program (n=102) Methadone program (n=99) 
N % N % 
Gender Women 38 37.3 35 35.4 
Men 64 62.7 64 64.6 
Age 41.03±11.80 34.48±8.88 
Education  Primary 17 16.7 28 28.3 
Secondary 35 34.3 28 28.3 
Secondary- 
professional 
39 38.2 32 32.3 
Higher 11 10.8 11 11.1 
Employment  Yes 32 31.4 39 40.0 
No 70 68.6 60 60.0 
Family Status  Married 29 28.4 19 19.2 
Divorced 16 15.7 13 13.1 
Widower 6 5.9 5 5.0 
Lives alone 15 14.7 16 16.2 
Unregistered 
relationship 
22 21.6 25 25.3 
Lives with parents 14 13.7 21 21.2 
Denies SUD 1 1.0 0 0 
 
While comparing both respondent group (Minnesota and Methadone program) results of TMQ, it can be seen that 
statistically significantly higher mean values are for respondents from Minnesota program (Table 2), for instance, in 
‘Internal Reason’ subscale (M=70.83; SD=6.87; p=0.015), ‘Help Seeking’ subscale (M=37.46; SD=5.18; p=0.007) 
and ‘Confidence’ subscale (M=29.36; SD=5.94; p=0.000), in comparison with mean values of Methadone program 
respondents (M=67.56; SD=11.49 and M=34.82; SD=8.23 and M=22.04; SD=6.95, respectively).   
In ‘External Reason’ subscale no statistically significant (p>0.05) differences were found, but the mean values for 
Minnesota program respondents were lower. 
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Table 2. Treatment  motivation questionnaire (TMQ) comparison of mean values between Minnesota and Methadone program patients 
Subscales Minnesota program (n=102) Methadone program (n=99) p 
Mean SD Mean SD  
External 
Reasons 
15.43 5.43 16.90 5.70 0.063 
Internal 
Reasons 
70.83 6.87 67.56 11.49 0.015 
Help Seeking 37.46 5.18 34.82 8.23 0.007 
Confidence 29.36 5.94 22.04 6.95 0.000 
 
In SOCRATES questionnaire (Table 3) within scales of ‘Recognition’ (p=0.001) and ‘Ambivalence’ (p=0.032) are 
statistically significant differences, higher mean values being within Minnesota program respondents (M=32.51; 
SD=3.21 and M=17.19; SD=2.22, respectively), in comparison with mean value results from Methadone program 
respondents (M=31.02; SD=3.33 and M=16.49; SD=2.42, respectively). 
There are no statistically significant differences in ‘Taking Steps’ scale (p>0.05). 
 
Table 3. SOCRATES questionnaire’s mean value comparison between Minnesota and Methadone program 
Subscales Minnesota program (n=102) Methadone program (n=99) p 
Mean SD Mean SD  
Recognition 32.51 3.21 31.02 3.33 0.001 
Ambivalence 17.19 2.22 16.49 2.42 0.032 
Taking Steps 34.20 4.20 34.33 3.08 0.800 
 
6. Discussion 
 
An important aspect of SUD patients starting the treatment is recognizing their problem and active help seeking. 
The internal, subjective factors play a major role for developing motivation for participation (Ryan, Plant, & 
O’Malley, 1995). Undoubtedly when speaking about SUD patients, external factors also have an impact on patient’s 
motivation, for instance, external pressure from family members, friends, or an event in patient’s life (Drieschner et 
al., 2004). However it is thought that primarily the motivation is regulated by internal processes of PAS addicted 
patient and external factors contribute for development of exactly internal motivation (Cahill et al., 2003).  
As the results of this research show, participants of Minnesota program have statistically significantly higher 
values in both SOCRATES (Recognition, Ambivalence subscales) and TMQ questionnaires (Internal Reasons, Help 
Seeking and Confidence subscales). In order to succeed in applying for Minnesota program, patient needs to have 
high motivation, the will of understanding himself better and recognition of the present addiction, whereas patients 
of the more passive substitution therapy are more likely to only receive the drug and less likely to admit the 
problem. 
Recognizing ambivalence indicates that patient can accept conflicting aspects of himself and his addiction, 
without denial (Miller & Tonigan, 1996). ‘Ambivalence’ together with higher rates of ‘Recognition’ shows that 
patients starting Minnesota program admit their addiction more and are usually ready for the treatment.  
Values of ‘Internal Reasons’ together with ‘Help Seeking’ and ‘Confidence’ reflect the subject’s expectation of a 
positive treatment outcome, motivation to share problems and relation to others during the course of treatment 
(Ryan, Plant & O'Malley, 1995). 
 
7. Limitation 
 
As a limiting factor one should mention the use of the convenience sample. Although the study used a 
psychometrically validated SOCRATES and TMQ survey, it is still a self-assessment questionnaire, and taking into 
account the personality structure of SUD patients, their difficulties in adequately assessing the reality and the lack of 
compliance, this might have influenced the results obtained.  
Also into account should be taken the fact that in Methadone program only drug addicted patients are taking part, 
whereas in Minnesota program both- drug as well as alcohol addicted patients participate. It might influence the 
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results, as the personality damage of drug addicts is more permanent, the use of primitive defence mechanisms more 
pronounced and with this, also the ability to admit their addiction can be disturbed. 
 
8. Conclusions 
 
Patients of Minnesota program show higher motivation rates in TMQ and SOCRATES questionnaires meaning 
higher motivation for treatment in comparison with patients of Methadone program. 
It is desired to continue research and compare addiction influence on motivation.    
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